Sheldon Zink, PhD, Rachel Zeehandelaar, and Stacey Wertlieb, MBe
The benefits of the international presumed-consent policy are presented as a solution to the United States' current shortage of organs available for transplantation.
Alcoholics should not be subject to deprioritization on a liver transplant waiting list if the belief is held that alcoholism is a disease and not an issue of moral failure for which the patient should be blamed.
Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.